A Convenient On-Site Oxidation Strategy for the N -Hydroxylation of Melanostatin Neuropeptide Using Cope Elimination.

Saved in:
Bibliographic Details
Title: A Convenient On-Site Oxidation Strategy for the N -Hydroxylation of Melanostatin Neuropeptide Using Cope Elimination.
Authors: Sampaio-Dias, Ivo E., Silva-Reis, Sara C., Pires-Lima, Beatriz L., Correia, Xavier Cruz, Costa-Almeida, Hugo F.
Source: Synthesis; Apr2022, Vol. 54 Issue 8, p2031-2036, 6p
Subject Terms: PARKINSON'S disease, PEPTIDE synthesis, PSYCHOLOGICAL adaptation, NEUROCHEMISTRY, PROLINE
Abstract: A convenient synthetic protocol for the unprecedented N -hydroxylation of proline residue in Melanostatin (MIF-1) neuropeptide is reported. This methodology is grounded on the incorporation of N -(cyanoethyl)prolyl residue followed by on-site oxidation by Cope elimination with m -chloroperbenzoic acid, exploring the unrecognized dual role of the cyanoethyl group as an effective N -protecting group under peptide synthesis conditions and as a suitable leaving group during the chemoselective on-site N -oxidation. Following this protocol N -hydroxy-MIF-1 is obtained in 78% global yield from N -(cyanoethyl)- l -proline. This synthetic approach opens a new avenue for access to N -hydroxylated Melanostatin analogues with direct application in neurochemistry and Parkinson's research. [ABSTRACT FROM AUTHOR]
Copyright of Synthesis is the property of Georg Thieme Verlag Stuttgart and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
Description
Abstract:A convenient synthetic protocol for the unprecedented N -hydroxylation of proline residue in Melanostatin (MIF-1) neuropeptide is reported. This methodology is grounded on the incorporation of N -(cyanoethyl)prolyl residue followed by on-site oxidation by Cope elimination with m -chloroperbenzoic acid, exploring the unrecognized dual role of the cyanoethyl group as an effective N -protecting group under peptide synthesis conditions and as a suitable leaving group during the chemoselective on-site N -oxidation. Following this protocol N -hydroxy-MIF-1 is obtained in 78% global yield from N -(cyanoethyl)- l -proline. This synthetic approach opens a new avenue for access to N -hydroxylated Melanostatin analogues with direct application in neurochemistry and Parkinson's research. [ABSTRACT FROM AUTHOR]
ISSN:00397881
DOI:10.1055/a-1695-1095